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1. Introduction
  Biosurfactants produced by microorganisms[1], are 
amphipathic surface active molecules containing 
hydrophilic and hydrophobic moieties that act by 
emulsifying hydrocarbons, increasing their solubilisation 
and subsequently rendering them available for microbial 
degradation[2]. They can be glycolipids, lipopeptides, 
lipopolysaccharides, polysaccharide protein complexes, 
fatty acids and lipids[3]. Bioemulsifiers generally include 
low-molecular-weight compounds, such as lipopeptides 
and glycolipids and bioemulsans include high-molecular-
weight polymers of polysaccharides, lipopolysaccharides, 
proteins or lipoproteins[4]. Biosurfactants are the most 
important and valuable products of biotechnology for 
industrial and medical applications. In recent years, these 
biomolecules were also found to possess several interesting 
properties of therapeutic and biomedical importance[5]. 
They have several applications including agriculture, 
bioprocessing, pharmaceuticals, food industry, dermatology 
and cosmetics industry. In pharmacological field, the 
biosurfactants act as antibacterial, antifungal, antiviral, 
anticancer, immunomodulator, anti-adhesive, antioxidants, 
stimulate dermal fibroblasts, vaccines and gene therapy[6]. 
  Microbes from extreme environments have attracted 
considerable attention in recent years. This is primarily 
due to the secret that they hold about the molecular 
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evolution of life and stability of the macromolecules[7]. 
They are often under extreme conditions of pressure, 
temperature, salinity, and depletion of micronutrients, with 
survival and proliferation often depending on the ability 
to produce biologically active compounds. The diversity 
of marine environments has exerted a driving force on 
bacteria selection leading to new adaptive strategies and 
the synthesis of new metabolites[8]. Microbial secondary 
metabolites have been recognized as a major source of 
compounds endowed with ingenious structures and potent 
biological activities. Marine microorganisms have been 
continuously found with unrivalled capacity to synthesize 
bioactive secondary metabolites. It has been reported that 
the number of novel marine natural compounds in 2008 
exceeded 1 000, most of which were isolated from indigenous 
or symbiotic microorganisms[9].
  The cyclic lipopeptide surfactin produced by Bacillus 
subtilis is one of the most powerful biosurfactant known 
today[10]. They are active at extreme temperatures, pH and 
salinity as well, and can be produced from industrial wastes 
and from by-products[11]. The lipopeptide biosurfactant are 
most prominently known as surfactin produced mostly by 
the Bacillus sp. Despite similar global structures, surfactins, 
iturins and fengycins differ in some aspects regarding their 
biological activities[10].
  The search for novel biosurfactants in extremophiles seems 
to be particularly promising since they have particular 
adaptations to increase stability in adverse environments 
and the microbial products are highly stable and important 
in medical biotechnology. The present study point out 
the screening, characterization and its pharmaceutical 
importance of biosurfactants extracted from the halophilic 
Bacillus sp BS3 which was isolated from solar salt works in 
southern India.
2. Materials and methods
2.1. Sampling 
  Condenser water had the salinity of 155曤 was collected 
from the solar salt works in Thamaraikulam, Kanyakumari 
district, Tamilnadu, India (Lat.  8o 11’ N and Long. 77o 
29’ E). Samples were collected in sterile polythene bags, 
transported to the laboratory aseptically and stored at 4 曟 
for further use.
2.2. Isolation and phenotypic identification
  Water samples were serially diluted from 10-1 to 10-8 in 
distilled water and 100 毺L of each dilution was spread 
onto sterile nutrient agar plates containing 5% to 20% NaCl. 
After incubation at 37 曟 for 7 d, morphologically different 
colonies were identified by Gram staining, motility and 
biochemical confirmations.
2.3. Genomic identification by 16S rRNA sequencing
  Genomic DNA (100 ng) isolated from halophilic Bacillus sp. 
BS3 strain was amplified by PCR using 16S rRNA universal 
primers (Forward: 5’ CAGGCCTAACACATGCAAGTC 3’; 
Reverse: 5’ GGGCGGWGTGTACAAGGC 3’). The PCR product 
was cloned into the vector pTZ57R and used to transform 
Escherichia coli DH5毩 as described by Maciel et al[12]. The 
transformants were sequenced using an ABI 3700 automated 
DNA sequencer. Sequences were compared with other 16S 
rRNAs obtained from GenBank using the BLAST program. 
The phylogenetic tree was constructed by MEGA5 software 
and evolutionary history was inferred using the UPGMA 
method[13]. The evolutionary distances were computed using 
the Maximum Composite Likelihood method[14] and are in 
the units of the number of base substitutions per site. The 
optimal tree with the sum of branch length = 0.316 626 28 is 
shown.
2.4. Biosurfactant screening
  Different biosurfactant screening methods were done for 
the potential biosurfactant producing halophilic Bacillus 
sp. BS3. The methods adopted were (a) drop-collapse test 
by adding mineral oil in 96-well microtitre plates[15]; (b) 
Oil spreading technique by adding weathered crude oil[16]; 
(c) Emulsification activity by adding kerosene and  equal 
volume of cell free supernatant[17] and (d) Hemolytic activity 
in 5% blood agar plate.
2.5. Biosurfactant extraction 
  The biosurfactant was extracted from cell-free broth at 
72-h grown cells by step-by-step purification of acid 
precipitates using adsorption chromatography. Bacterial 
cells were removed from surfactant-containing medium by 
centrifugation (10 000 rpm for 20 min). The supernatant was 
subjected to acid precipitation by adding 6 N HCl to achieve 
a final pH of 2.0 and allowing the precipitate to form at 4 曟.
The precipitate was pelleted at 10 000 rpm for 20 min, re-
dissolved in distilled water, adjusted to pH 7.0, freeze-
dried, and weighed. The dried surfactant was extracted with 
acetone and dried with the aid of a rotary evaporator under 
vacuum[18].
2.6. Partial purification and structural elucidation
2.6.1. Thin-layer chromatography (TLC)
  The dried biosurfactants obtained from acid precipitation 
method was dissolved with distilled water and spotted on 
TLC (Merck) sheets and run with CHCl3/CH3OH/H2O (65:15:1) 
as mobile phase. The chromatogram was developed under 
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short UV light as well as exposing iodine vapour. The 
Rf value was calculated as per the standard database of 
biosurfactants[19].
2.6.2. Fourier transmission infrared spectroscopy (FT-IR)
  The basic functional groups of the purified Biosurfactants 
from halophilic Bacillus sp. BS3 were analyzed qualitatively 
by Fourier Transform Infra Red (FTIR)[20].  
2.6.3. Gas chromatography- Mass spectrometry (GC-MS) 
  GC-MS analysis of partially purified biosurfactants were 
analysed individually using Agilent GC-MS 5975 Inert XL 
MSD (United States) gas chromatography equipped with J 
and W 122-5532G DB-5 ms 30 mm 暳 0.25 mm 暳 0.25 毺m 
and mass detector (EM with replaceable horn) was operated 
in EMV mode. Helium was used as carrier gas with the flow 
rate of 1.0 mL/ min. The injection port temperature was 
operated at 250 曟. The column oven temperature was held 
at 80 曟 for 2 min then programmed at 10 曟 per minute 
to 250 曟, which was held for 0 min, and then at 5 曟 per 
minute to 280 曟 which was held for 9 min.  Electron impact 
spectra in positive ionization mode were acquired between 
m/z 40 and 450.
2.7. Pharmacological potential of halophilic Bacillus sp 
Biosurfactants
2.7.1. Antibacterial and antifungal activity
  In vitro antibacterial activity was performed by the 
partial purified biosurfactants against human pathogens 
(Escherichia coli, Pseudomonas aerugenosa, Salmonella 
typhi and Staphylococcus aureus) using agar diffusion 
method and agar over layer method. For anti fungal activity,
20 毺L of extract was poured into the well of the Potato 
Dextrose Agar plates and fungal spores were inoculated 
onto the plates and incubated at 35 曟 for 48 h. The zone of 
inhibition was recorded.
2.7.2. Antiviral activity
  Antiviral activity was performed against white 
spot syndrome virus (WSSV) following the method of 
Balasubramanian et al[21]. Five micro litre of purified 
WSSV suspension (300 毺g of total protein) was mixed with 
different percentages of biosurfactants (25%, 50%, 75% and 
100%) and incubated at 29 曟 for 3 h. After incubation period, 
the mixture was injected intramuscularly to Fenneropenaeus 
indicus and had the average weight of (10暲1) g. Three 
replicates were (n= 10暳3= 30) maintained in all treatments. 
Mortalities were recorded daily and the experiment was 
carried out up to 10 d. Control shrimps were injected with a 
mixture of 10 毺L NTE buffer and 5 毺L viral suspensions. 
Haemolymph samples were collected from all injected 
shrimps and checked by WSSV diagnostic PCR using VP 
28 primer designed by Yoganandhan and Sahul Hameed[22] 
The DNA extraction and PCR amplification were carried 
out by following the method described by Islam et al[23]. 
Haemolymph samples of experimental and control shrimps 
were tested by the first step PCR. The negative samples 
detected in the first step were further subjected for second 
step PCR analysis.
2.7.3. Anticancer activity
  The anticancer activity was performed in tumor mammary 
epithelial carcinoma cell lines with the partial purified 
biosurfactants extracted from halophilic Bacillus sp. 
following the method of Freshney[24] and the activity was 
monitored after 48 h.  
 
3. Results
3.1.  Identification of halophilic Bacillus sp.
  Among the various isolates from the solar salt works, the 
effective biosurfactant producing bacteria was confirmed as 
Bacillus sp. by morphological, biochemical and 16S rRNA 
sequencing. The phenotypic confirmation revealed that, the 
Bacillus sp. BS3 are gram positive, rod shape, non motile and 
able to ferment carbohydrate such as glucose, sucrose and 
galactose (Table 1). Phylogenetic and evolutionary analysis of 
the 16S rRNA sequence revealed that, the halophilic Bacillus 
sp. BS3 was more than 90% similarity to the other Bacillus 
sp. such as Bacillus cereus, Bacillus anthracis, Bacillus 
thuringiensis and other uncultured bacterium (Figure 1). 
Table 1
Phenotypic identification of biosurfactant produced halophilic 
Bacillus sp. BS3 isolated from Thamaraikulam solar salt works in 
India. 
Sl. No Confirmative test Bacillus sp. BS3
  1 Gram staining +
  2 Cell shape rod
  3 Motility -
  4 Indole -
  5 Methyl red -
  6 VP -
  7 Citrate +
  8 Oxidase -
  9 Catalase +
10 Nitrate +
11 Urease +
12 TSI -
13 Gelatin hydrolysis +
14 Starch hydrolysis +
15 CHO fermentation Glucose
Sucrose
Galactose
Lactose
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Figure 1. Evolutionary relationships of biosurfactant producing 
halophilic Bacillus sp. BS3’s 16S  rRNA sequence compared with other 
taxa. 
3.2. Biosurfactant screening
  Of the different biosurfactant screening tests such as drop 
collapse test, oil spreading test, emulsification activity and 
haemolytic activity, the halophilic Bacillus sp. BS3 was 
able to produce biosurfactants. The halophilic Bacillus 
sp. was highly positive in those tests, whereas very low 
or no activities were observed in compared with the 
Bacillus subtilis isolated from back water and MTCC strains 
respectively (Table 2). 
3.3. Partial purification and structural elucidation
  The extracted biosurfactants’ relative front (Rf) was 
calculated 0.68 of the chromatogram developed in TLC. 
Based on the Rf value database, it was concluded that, the 
extracted biosurfactant from halophilic Bacillus sp belongs 
to lipopetide type (Figure 2). The different peak of the IR 
spectral analysis revealed that, the stretch, 3 429 cm-1 
denoted as N-H group. The presence of this peak reveals the 
fact that the sample contains a primary or secondary amine 
or an amide or substituted amide group in the sample. 
The peak at 2 084 cm-1 corresponds to cumulated system 
like R2C=N=N in the sample. The presence of the peak at 
1 641 cm-1 confirms the presence of olefininc band (C=C) is 
unsaturation and the peak at 406 cm-1 is due to C-I (Carbon 
-Iodine) bond (Figure 3). The various retention times of 
the biosurfactants’ GC-MS and NIST 98 and 2005 database 
analysis revealed that, the peak from different retention 
times such as  29.57, 29.59, 29.60, 30.58, 13.51, 16.09 and 
16.22 confirmed as 13-Docosenamide, (Z); Mannosamine, 
9-Octadecenamide, (Z), 2-Octanol, 2-methyl-6-methylene, 
Cylohex-1,4,5-triol-3-one-1-carbo, 2-Butanamine, 
2-methyl- and 1,2-Ethanediamine, N,N,N’,N’-tetramethyl- 
respectively (Table 3). 
Table 2
Biosurfactant screening halophilic Bacillus sp. isolated from 
Thamaraikulam solar salt works in India. 
Bacterial
strains
Drop 
collapse test
Oil spreading
test
Emulsification
activity
Haemolytic
activity
Halophilic
Bacillus sp.*
++++ +++ ++++ ++++
Bacillus
subtilis
(MTCC)**
- - - -
Bacillus
subtilis*** 
++ + + +
* Biosurfactant produced Bacillus sp. BS3 isolated from solar salt 
works; ** Bacillus subtilis from MTCC strain (IMTECH, Chandigar, 
India) and *** Bacillus subtilis from isolated from back water of 
Rajakkamangalam, India.
0.68
Figure 2. Qualitative analysis of partially purified biosurfactants by 
TLC.
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Figure 3. FTIR analysis for the partially purified biosurfactant from 
halophilic  Bacillus sp. BS3.
3.4. Pharmacological potential of biosurfactants
  The Bacillus sp. BS3’s biosurfactants were effectively 
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inhibited the growth of the pathogenic bacteria as well as 
fungi (Table 4). The antibacterial activity observed was 
16.00, 14.06, 13.10 and 10.10 mm of zone of inhibition against 
Escherichia coli, Staphylococcus aureus, Pseudomonas 
aeruginosa and Salmonella typhi, respectively. Also higher 
antifungal activity observed against Trichophyton rubrum, 
Aspergillus niger less activity against Aspergillus flavus 
and Fusarium sp. respectively. The antiviral effect of 
the biosurfactant against WSSV revealed that, the higher 
percentages (50%, 75% and 100%) of biosurfactant were 
effectively suppressed the WSSV control (Figure 4). The 
WSSV injected shrimp succumbed to death cent percent 
at 5 d whereas the surfactant treated groups had prolonged 
survival and less mortality of 70% and 90% at the end of 
experiment (P<0.05). One step PCR detection also supported 
the higher percentages of biosurfactants. There no positive 
PCR signals observed in 75% and 100% of biosurfactants 
due to cent percent of viral suppression found (Figure 5). 
Various concentrations of biosurfactants treated mammary 
epithelial carcinoma cell were given in the Figure 6. The 
concentrations of 0.000 25 毺g suppressed the cells of 7.42%; 
0.002 5 at 16.44%; 0.025 at 21.66% and 0.25 at the maximum 
of 24.8% and significantly varied (P<0.05). 
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Figure 4. Survival of Penaeus monodon after injection with partially 
purified biosurfactant of halophilic Bacillus sp. BS3 incubated with 
WSSV.
Table 4
In vitro antibacterial and antifungal activity of partial purified 
biosurfactants from halophilic Bacillus sp BS3.
Sample 
No.
Antibacterial activity Antifungal activity
Bacterial 
pathogens
Activity (mm of 
zone of inhibition)
Fungal pathogens Activity
1 E. coli 16.00 暲 0.15 T. rubrum ++++
2 S. aureus 14.06 暲 0.12 A. niger ++++
3 P. aeruginosa 13.10 暲 0.12 A. flavus ++
4 S. typhi 10.10 暲 0.13 Fusarium sp. ++
++++: higher activity; ++: medium activity; +: less activity.
M              1               2              3              4             5              6
10 kbp
5 kbp
1 kbp
750 bp
500 bp
250 bp
624 bp
Figure 5. Antiviral screening of partially purified biosurfactant of 
halophilic Bacillus sp BS3 against WSSV by PCR detection. 
Lanes M-Marker; 1-Positive control; 2-Negetive control; 3%-25%; 4%-
50%; 5%-75% and 6%-100% biosurfactant incubated with WSSV and 
injected to Penaeus monodon. 
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Figure 6. Anticancer activity performed in tumor mammary epithelial 
carcinoma cell lines with partial purified biosurfactants extracted from 
halophilic Bacillus sp. BS3.
Table 3
Major chemical compounds identified from the partial purified biosurfactants from halophilic Bacillus sp. BS3 by GCMS analysis.
Retention time Name of  compounds Molecular  formula Molecular weight Quality %
29.57 13-Docosenamide, (Z) CH3(CH2)7CH=CH(CH2)11CONH2 337.58 93
29.59 Mannosamine C6H13NO5.HCl 215.60 45
29.60 9-Octadecenamide, (Z) C18H35NO 281.40 72
30.58 2-Octanol, 2-methyl-6-methylene C12H22O2 198.30 43
13.51 Cylohex-1,4,5-triol-3-one-1-carbo C5H8FN3 129.13 64
16.09 2-Butanamine, 2-methyl- C5H13N   87.16 38
16.22 1,2-Ethanediamine, N,N,N’,N’-tetramethyl- C6H16N2 116.20 80
MBS Donio et al./Asian Pacific Journal of Tropical Medicine (2013)876-883 881
4. Discussion
  Besides their role in hydrocarbon bioremediation and 
microbial enhanced oil recovery[25], these biological 
products have potential uses in agriculture and the cosmetic, 
pharmaceutical, detergent, food, textile, paper and paint 
industries[26]. The biosurfactants of halophilic Bacillus sp. 
BS3 seems to increasing stability in the harsh environments 
and the strain grow well, higher emulsification stability in 
higher salinity, temperature and pH. Seghal Kiran et al[10] 
demonstrated that the biosurfactant produced by Bupleurum 
aureum MSA13 was stable even at autoclaving and the 
biosurfactant produced by marine actinobacterium was 
stable at high NaCl. Such extreme stability was reported by 
Abdel- Mawgoud et al[27] for the Psudomonas aeruginosa 
strain.
  The lipopeptide biosurfactant are most prominently known 
as surfactin produced mostly by the Bacillus sp. Despite 
similar global structures, surfactins, iturins and fengycins 
differ in some aspects regarding their biological activities. 
For instance, iturins and fengycins display a strong 
antifungal activity, while surfactins are not fungitoxic by 
themselves. Surfactins show weak antibacterial properties 
but iturins may be strongly inhibitory to the growth of some 
gram-positive bacteria[10]. In the present study different 
screening methods such as drop collapse test, oil spreading 
test, emulsification activity and haemolytic activity were 
the simplest and powerful tools for the primary screening 
for biosurfactants. The methods supported for positive 
production of biosurfactants in the halophilic Bacillus sp. 
BS3 in compare with other Bacillus subtilis sp. The anti-
adhesion activity of lipopeptide biosurfactants from Bacillus 
spp. was shown to prevent biofilmformation by bacterial 
human pathogens[28]. The cyclic lipopeptide surfactin, 
produced by Bacillus subtilis ATCC 21332, is one of the most 
powerful biosurfactants. Lakshmipathy et al[29] screened 
the amphipathic extracellular lipopeptides biosurfactant 
production in marine actinomycetes, Streptomyces spp. 
VITDDK3 by conventional screening methods, including 
hemolytic, drop collapsing and lipase production activity. 
  Bacillus sp. has been reported as the major producer of 
biosurfactants including lipopeptides, glycolipids, surfactin 
and halobacillin etc. The present study TLC analysis revealed 
that, the Rf value of 0.68 was confirmed as lipopeptide[30]. The 
lipopeptide biosurfactant was characterized from Bacillus 
circulans by FTIR and TLC analysis[5]. The GC-MS analysis 
revealed that, the biosurfactant of halophilic Bacillus sp. 
BS3 contain glycolipids, polymers and other compounds 
including 13-Docosenamide, (Z); Mannosamine, 9- and 
N,N,N’,N’-tetramethyl etc. The ether extract of endophytic 
fungus Paecilomyces sp. contain 13-Docosenamide, (Z) had 
significant antifungal and antitumor properties. The other 
compound, mannosamine is responsible for the formation 
of saccharides in different species of Bacillus. The present 
study, the biosurfactant contain mannosamine at the 
quality of 45% and 9-Octadecenamide, (Z) at 72% quality 
level. D-mannosamine and D (+)-mannose which was 
isolated from the ovary of cobia Rachycentron canadum had 
antibacterial activity against Escherichia coli and mitogenic 
activity reported by Ngai and Ng[31]. The sponge associated 
actinomycetes, Nocardiopsis dassonvillei MAD08 contain 
9-octadecenamide, (Z) had the broad range of antimicrobial 
activity including anticandid activity[32]. 1,2-Ethanediamine, 
N,N,N’,N’-tetramethyl- is a polymeric biosurfactant also 
present in the biosurfactant of  the Bacillus sp. BS3 at high 
quality level. 1,2-Ethanediamine, N,N,N’,N’-tetramethyl- 
had a broad pharmacological activities including anti tumor, 
antifungal activities, fouling in aqueous system and shown 
to be microbicidal and preventing adhesion of bacteria. 
Bacillus subtilis lipopeptide biosurfactant was also used for 
control of Culex quinquefasciatus[33], Anopheles stephensi[34] 
and Aedes aegypti[35]. Interestingly, Bacillus subtilis has been 
reported as a biological control agent against Spodoptera 
littoralis[36].
  Lipopeptides can act as antibiotics, antiviral and 
antitumour agents, immunomodulators or specific toxins 
and enzyme inhibitors[15]. The lipopeptides showed higher 
activity against gram-positive cocci than against gram-
negative bacilli[37]. The present results revealed that, the 
biosurfactants extracted from halophilic Bacillus BS3 
were able to suppress the bacterial sp of Escherichia 
coli, Staphylococcus aureus, Psudomonas aeruginosa and 
Salmonella typhi at more than 10 mm of zone of inhibition. 
The biosurfactant may inhibit the cell wall synthesis and 
inhibit the protein synthesis of the bacteria. Mukherjee et 
al[38] purified a biosurfactant from marine Bacillus circulans 
exhibit enhanced surface and antimicrobial activities. It 
is well known that some types of biosurfactants produced 
by several Bacillus species exhibit antimicrobial activity 
against many bacteria, including pathogens[5]. Bacillus 
amyloliquefaciens ES-2 from Scutellaria baicalensis 
coproduces surfactins and fengycins with antimicrobial 
activities against some phytopathogenic food-borne 
pathogenic and spoilage bacteria and fungi[39]. Surfactin 
from Bacillus subtilis was reduce the adhesion and to 
disrupt biofilms of food-borne pathogenic bacteria. These 
molecules were strong surface activity, emulsion forming 
ability and has shown antimicrobial properties[40,41]. The 
antifungal activity against phytopathogenic fungi has been 
demonstrated for glycolipids, such as cellobiose lipids[42], 
rhamnolipids[43], and cyclic lipopeptides[44]. Arena et 
al[45] reported novel type of EPS-1 polysaccharide had an 
antiviral and immunomodulatory effect which was produced 
by thermo tolerant strain Bacillus licheniformis. The 
characteristic structural element in lipopeptidesis a specific 
fatty acid, which was combined with an amino acid moiety. 
As a consequence of this amphiphilic structure, lipopeptides 
have various interesting biologicalproperties. They exhibit 
antifungal properties, moderate antibacterial and hemolytic 
properties, induce the formationof ion channels in lipid 
bilayer membranes, and exhibit antitumorand anti-viral 
activities[46]. The biosurfactant incubated WSSV injected 
shrimps showed higher survival rate compared with the 
control. The 100% biosurfactant treated group had increased 
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the survival rate (3 times). The biosurfactants may suppress 
the viral transcription and replication. Surfactin is one of 
the most powerful biosurfactants and is known to have anti-
inflammatory, antibiotic and anti-tumour functions[47]. 
Cao et al[48] demonstrated that surfactin induces apoptosis 
in human breast cancer MCF-7 cells through a ROS/JNK-
mediated mitochondrial/caspase pathway. An antitumour 
lipopeptide biosurfactant purified from Bacillus natto 
TK-1 was able to inhibit the proliferation of MCF-7 human 
breast-cancer cells[49]. Kim et al[50] reported that lipopeptide 
shows an antiproliferative effect on human colon carcinoma 
LoVo cells via apoptosis induction and cell-cycle arrest at 
G1-phase. Antimicrobial lipopeptides produced by Bacillus 
subtilis FMBJ inactivated the cell-free virus of porcine 
parvovirus, pseudorabies virus, newcastle disease virus and 
bursal disease virus, while it effectively inhibited replication 
and infectivity of the Newcastle disease virus and bursal 
disease virus[51]. Also a rhamonolipid and its complex 
with alginate, both produced by a Pseudomonas sp. strain, 
showed significant antiviral activity against herpes simplex 
virus types 1 and 2[52]. The present findings revealed that the 
biosurfactant isolated from the halophilic Bacillus sp. BS3 
had wider pharmacological activities and this will helps to 
develop novel drugs. Further studies are needed to improve 
the biosurfactant production and purification of the various 
compounds such as lipopeptides, glycolipids and polymers 
from the Bacillus sp. BS3.
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